- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Renal cell carcinoma with inferior vena cava thrombus: Survival and prognostic factors in surgically treated patients.
December 3, 2024
STAT2/SLC27A3/PINK1-Mediated Mitophagy Remodeling Lipid Metabolism Contributes to Pazopanib Resistance in Clear Cell Renal Cell Carcinoma.
December 2, 2024
Late Survival and Long-Term Follow-Up After Radical Resection of Advanced Renal Cell Carcinoma With Associated Venous Tumor Thrombus.
December 2, 2024
Comparison of outcomes between single-port and multi-port robotic radical nephrectomy.
November 29, 2024
Adverse events after nivolumab and ipilimumab combined immunotherapy in advanced renal cell carcinoma: a multicentre experience in Poland.
November 29, 2024
Primary resistance to nivolumab plus ipilimumab therapy affects second-line treatment outcomes in patients with metastatic renal cell carcinoma.
November 28, 2024
Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study.
November 27, 2024
Synchronized autologous T-cell immunotherapy with hyperthermia to previously heavy treated advanced renal cell carcinoma.
November 26, 2024
Association between the systemic inflammation response index and kidney stones in US adults: a cross-sectional study based on NHANES 2007-2018.
November 26, 2024
CD70: An Emerging Anticancer Target in Renal Cell Carcinoma and Beyond.
November 25, 2024
Risk factors for kidney cancer and socio-occupational category: significant impact of chlorinated solvents (UroCCR 111).
November 25, 2024
Robot-assisted partial nephrectomy vs. percutaneous cryoablation for T1a renal tumors: a single-center retrospective analysis of outcomes and costs.
November 25, 2024
Decoy-resistant IL-18 reshapes the tumor microenvironment and enhances rejection by anti-CTLA-4 in renal cell carcinoma.
November 22, 2024